CCL20 and neoplasm: Notably, in tumor models, Th9 cells aid in promoting cytotoxic CD8+ T cells expansion and activation, through CCL20/CCR6-dependent recruitment of type 1 dendritic cells (DC1), specialized for the cross-presentation of antigen by MHC class I molecules to CD8+T cells.41